Fundraising FoxIntact Vascular
Wayne, US · Founded 2011 · 7 known investors
Find your way into Intact Vascular
Sign up to see every warm intro you have to Intact Vascular
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intact Vascular team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Intact Vascular develops interventional vascular medical devices intended for use by physicians trained in interventional techniques. The company is associated with Philips.
Founders & leadership
Intact Vascular was founded in 2011 by Robert Giasolli and Bruce J. Shook.
RG
Robert GiasolliCo-founder
BJ
Bruce J. ShookCo-founder
CB
Carol BurnsExecutive
MP
Marc PennaExecutive
MK
Monica KlosExecutive
ML
Michael LongoExecutive
JC
Joseph C. Griffin, IIIExecutive
Board
Investors · 7
415 Capitallisted by 415 CapitalMunich · $5.4M – $16.2M
How we know: 415 Capital's portfolio page · Not right? Tell us
H.I.G. BioHealth Partnerslisted by H.I.G. BioHealth Partners
How we know: H.I.G. BioHealth Partners's portfolio page · funding news · Not right? Tell us
H.I.G. HealthBridge Partnerslisted by H.I.G. HealthBridge PartnersMiami · $5M – $40M
How we know: H.I.G. HealthBridge Partners's portfolio page · Not right? Tell us
Runway Growth Capitallisted by Runway Growth CapitalMenlo Park
How we know: Runway Growth Capital's portfolio page · Not right? Tell us
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40M
How we know: funding news · Not right? Tell us
Vensana CapitalreportedMinneapolis
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements$73.2M disclosed across 7 of 8 rounds · 2011–2020
- Undisclosed amountSeries BJan 2017 · 2 sourcesSource ↗
▶$13.5MraisedMay 2020 · 4 investors · Other Health CareRule 506(b)
▶$13.5MraisedMay 2020 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Josh MakowerDirector
- Bruce J. ShookExecutive Officer, Director
- Peter Justin KleinDirector
- P. Sherrill NeffDirector
- Dennis W. WahrDirector
- Peter SchneiderExecutive Officer, Director
- Joseph C. Griffin, IIIExecutive Officer
- Douglas G. EvansExecutive Officer, Director
- Monica KlosExecutive Officer
- Bruce RobertsonDirector
- Offering amount
- $15M
- Amount sold
- $13.5M
- Proceeds to insiders
- $1M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedJun 2019 · 1 investors · Other Health CareRule 506(b)
▶$5MraisedJun 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter SchneiderDirector
- Josh MakowerDirector
- Douglas EvansDirector
- Bruce RobertsonDirector
- Stephen G. MacKinnonExecutive Officer
- Marc PennaExecutive Officer
- Howard RosenExecutive Officer
- Michael LongoExecutive Officer
- Joseph C. Griffin, IIIExecutive Officer
- Monica KlosExecutive Officer
- Dennis W. WahrDirector
- Bruce J. ShookExecutive Officer, Director
- P. Sherrill NeffDirector
- Offering amount
- $25M
- Amount sold
- $5M
- Proceeds to insiders
- $5.1M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedApr 2018 · 3 investors · Other Health CareRule 506(b)
▶$10MraisedApr 2018 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas G. EvansDirector
- Justin KleinDirector
- Howard RosenExecutive Officer
- Aaron DavidsonDirector
- Bruce J. ShookExecutive Officer, Director
- P. Sherrill NeffDirector
- Monica KlosExecutive Officer
- Michael LongoExecutive Officer
- Dennis WahrDirector
- Joseph C. Griffin, IIIExecutive Officer
- Marc PennaExecutive Officer
- Offering amount
- $21.8M
- Amount sold
- $10M
- Proceeds to insiders
- $2.1M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$39.3MraisedJan 2017 · 8 investors · Other Health CareRule 506(b)
▶$39.3MraisedJan 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter SchneiderExecutive Officer, Director
- Marc PennaExecutive Officer
- Monica KlosExecutive Officer
- Dennis WahrDirector
- Justin KleinDirector
- P. Sherrill NeffDirector
- Michael LongoExecutive Officer
- Joseph C. Griffin, IIIExecutive Officer
- Aaron DavidsonDirector
- Douglas G. EvansDirector
- Bruce J. ShookExecutive Officer, Director
- Offering amount
- $39.3M
- Amount sold
- $39.3M
- Proceeds to insiders
- $4.9M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$3MraisedMar 2015 · 15 investors · Other Health CareRule 506(b)
▶$3MraisedMar 2015 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Katherine D. CrothallDirector
- Douglas G. EvansExecutive Officer, Director
- Bruce J. ShookExecutive Officer, Director
- P. Sherrill NeffDirector
- Joseph C. GriffinExecutive Officer
- Aaron DavidsonDirector
- Peter SchneiderDirector
- Bryan A. ClasemanExecutive Officer
- Holly HarrityExecutive Officer
- Marc PennaExecutive Officer
- Dennis WahrDirector
- Offering amount
- $5.5M
- Amount sold
- $3M
- Proceeds to insiders
- $710K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.3MraisedFeb 2012 · 2 investors · BiotechnologyRule 506(b)
▶$1.3MraisedFeb 2012 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carol A. BurnsExecutive Officer, Director
- Peter SchneiderExecutive Officer, Director
- Brian WalshDirector
- Robert GiasolliExecutive Officer
- Katherine D. CrothallDirector
- Offering amount
- $3.5M
- Amount sold
- $1.3M
- Proceeds to insiders
- $250K
- First sale
- Feb 2012
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06
▶$1.1MraisedJan 2012 · 25 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJan 2012 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GiasolliExecutive Officer
- Peter SchneiderDirector
- Carol BurnsExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- Proceeds to insiders
- $465K
- First sale
- Oct 2011
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Intact Vascular do?
- Intact Vascular develops interventional vascular medical devices intended for use by physicians trained in interventional techniques. The company is associated with Philips.
- Who founded Intact Vascular?
- Intact Vascular was founded by Robert Giasolli, Bruce J. Shook in 2011.
- Who are Intact Vascular's investors?
- Intact Vascular's investors include 415 Capital, H.I.G. BioHealth Partners, H.I.G. Capital, H.I.G. HealthBridge Partners, Runway Growth Capital, New Enterprise Associates (NEA), Vensana Capital.
- How much funding has Intact Vascular raised?
- Intact Vascular has disclosed $73.2M raised across 7 of its 8 known rounds.
- Where is Intact Vascular headquartered?
- Intact Vascular is headquartered in Wayne, US.